Related content

Adrenergic targets for the treatment of cognitive deficits in schizophrenia

By Arnsten Amy  

Psychopharmacology, Vol. 174, Iss. 1, 2004-06 ,pp. : 25-31

Springer Publishing Company

Access to resources Recommend Favorite

The Attentional Set-Shifting Test Paradigm in Rats for the Screening of Novel Pro-Cognitive Compounds with Relevance for Cognitive Deficits in Schizophrenia

By  

Current Pharmaceutical Design, Vol. 20, Iss. 31, 2014-09 ,pp. : 5060-5068

Bentham Science Publishers

Access to resources Recommend Favorite

Treating the Cognitive Deficits of Schizophrenia with Alpha4Beta2 Neuronal Nicotinic Receptor Agonists

By  

Current Pharmaceutical Design, Vol. 16, Iss. 3, 2010-01 ,pp. : 309-322

Bentham Science Publishers

Access to resources Recommend Favorite

Nicotinic Receptors and the Treatment of Attentional and Cognitive Deficits in Neuropsychiatric Disorders: Focus on the 7 Nicotinic Acetylcholine Receptor as a Promising Drug Target for Schizophrenia

By  

Central Nervous System Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Central Nervous System Agents), Vol. 7, Iss. 4, 2007-12 ,pp. : 269-288

Bentham Science Publishers

Access to resources Recommend Favorite

Treating Schizophrenia: Novel Targets for the Cholinergic System

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 9, Iss. 2, 2010-04 ,pp. : 241-256

Bentham Science Publishers

Access to resources Recommend Favorite